SLEDAI-2K activity score : inferior to 5 for quiescent patients, superior to 8 since at least 2 months for active patients
You may not be if
\-- Other autoimmune diseases than SLE- Induced lupus
Treatment with corticosteroids \>10mg/d (prednisone) for quiescent patients
Treatment with corticosteroids \>20mg/d (prednisone) for active patients
Oral immunosuppressive treatment during the last 6 months (methotrexate, azathioprine, ciclosporine, mycophénolate mofétil) for all patients, treatment during the last year with cyclophosphamide or monoclonal antibodies (rituximab, belimumab) for pour quiescent patients
Disease which can modify B and T lymphocyte functions: primary immune deficiencies, evolutive infections, chronic viral infection (VIH in particular), chemotherapy or neoplasm antecedent
Clareo Health | Anti-nucleosome B Lymphocytes in Lupus
